Menu Back to 09

Track 9: Regulatory

DIA 2017: Driving Insights to Action

This track is composed of sessions addressing global laws, regulations, guidelines, and guidances that govern prescription biopharmaceutical and device product development, approval, and maintenance. Representatives from FDA, Health Canada. NMPA, PMDA, EMA, MHRA, European Health Authorities and ICMRA authorities, and other regulatory experts will provide global updates, insights, and discussion on current issues through interactive forums. Themes commonly revolve around Global Regulatory Changes and Impact on Global Development Strategies, Global Harmonization/Convergence and Impact on Drug Development and Advances and Innovations to Improve the Practice of Regulatory Affairs, and Regulatory Hot Topics are always prominently featured.

Sessions in Regulatory

Monday, June 21-Friday, June 25 | Short Courses

View All Short Courses

Monday, June 28

Tuesday, June 29

Wednesday, June 30

Thursday, July 1

Who is This Track Designed For?

Professionals involved in: Regulatory affairs and strategy, regulatory operations, regulatory information management, regulatory agencies, government affairs, legal affairs and compliance, policy and intelligence, clinical research and operations, PV, HTA, project management, and service providers developing tools and resources for use by sponsors and CROs.

View Other Tracks


Registration Rates

Back to DIA 2021

Back to DIAglobal.org